X, L., X, J., & H, N. (2018). Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy. Dove Medical Press.
Cita Chicago Style (17a ed.)X, Li, Jia X, y Niu H. Nanostructured Lipid Carriers Co-delivering Lapachone and Doxorubicin for Overcoming Multidrug Resistance in Breast Cancer Therapy. Dove Medical Press, 2018.
Cita MLA (8a ed.)X, Li, et al. Nanostructured Lipid Carriers Co-delivering Lapachone and Doxorubicin for Overcoming Multidrug Resistance in Breast Cancer Therapy. Dove Medical Press, 2018.
Precaución: Estas citas no son 100% exactas.